1 | motion | 6,103 |
2 | spondyloarthritis | 117 |
3 | synechiae | 75 |
4 | wall-motion | 55 |
5 | self-motion | 24 |
6 | fontanelle | 17 |
7 | stress-velocity | 10 |
8 | fontanel | 8 |
9 | myofibres | 8 |
10 | pronation/supination | 8 |
11 | hunger/satiety | 5 |
12 | semifundoplication | 5 |
13 | aminopeptidases | 4 |
14 | chemoradiosensitivity | 4 |
15 | pellitory | 4 |
16 | stress-length | 4 |
17 | cordgrass | 3 |
18 | dose-timing | 3 |
19 | microscotomas | 3 |
20 | pre-rrnp | 3 |
21 | stress/fractional | 3 |
22 | striation | 3 |
23 | 2.7l | 2 |
24 | 5750 | 2 |
25 | bloom/wax | 2 |
26 | cac≥22 | 2 |
27 | d'hebron | 2 |
28 | dermatovenerology | 2 |
29 | dilitation | 2 |
30 | hyper-crosslinked | 2 |
31 | iqol | 2 |
32 | life-100bref | 2 |
33 | npsuns | 2 |
34 | perimitral | 2 |
35 | periventricularis-nucleus | 2 |
36 | stress-lvef | 2 |
37 | stress-rate-corrected | 2 |
38 | stress/rate-corrected | 2 |
39 | β1,6-glucans | 2 |
40 | 16,689 | 1 |
41 | 19.1-26.2°c | 1 |
42 | 2/nl | 1 |
43 | 3-hydroxy-3-phenylpropanoate | 1 |
44 | 300-900°c | 1 |
45 | 57.2/year | 1 |
46 | a-l. | 1 |
47 | a-peak | 1 |
48 | addo | 1 |
49 | ades-over-time | 1 |
50 | af.kidney | 1 |
51 | amiodarone-treatment | 1 |
52 | antimotion | 1 |
53 | area/total | 1 |
54 | chromium/animal/day | 1 |
55 | clostridiumthermocellum | 1 |
56 | condoms/protection | 1 |
57 | crp/crp | 1 |
58 | date.an | 1 |
59 | defect/pulmonary | 1 |
60 | deficient/defective | 1 |
61 | dephenylation | 1 |
62 | electroencephalogam | 1 |
63 | enzyme/hemodynamics | 1 |
64 | frontal-temporal-limbic | 1 |
65 | gamma-frequency | 1 |
66 | gaze-following | 1 |
67 | head-imaging | 1 |
68 | hypertension/the | 1 |
69 | independent-components | 1 |
70 | invasion-like | 1 |
71 | iptsp | 1 |
72 | laminectomy/discectomy | 1 |
73 | ld50/bee/day | 1 |
74 | letters/digits | 1 |
75 | mahé | 1 |
76 | mass/end | 1 |
77 | maxilla-mandibular | 1 |
78 | micro-embolisation | 1 |
79 | mitral-peak | 1 |
80 | movement×mirror | 1 |
81 | near-falls | 1 |
82 | neseritide | 1 |
83 | nrs≥5 | 1 |
84 | orizaba | 1 |
85 | oscata | 1 |
86 | palf-702 | 1 |
87 | paresthaesia | 1 |
88 | passivator | 1 |
89 | patient-actors | 1 |
90 | pb1-egfp | 1 |
91 | pdcai | 1 |
92 | pneumococcusuria | 1 |
93 | polypharmacy-related | 1 |
94 | ponv/motion | 1 |
95 | porthole | 1 |
96 | prefrontals | 1 |
97 | pulses/heifer | 1 |
98 | putamenat | 1 |
99 | rhophylac | 1 |
100 | running.future | 1 |
101 | score/standard | 1 |
102 | segment-lengthening | 1 |
103 | skull-induced | 1 |
104 | stress-endocardial | 1 |
105 | supermicropores | 1 |
106 | surgeons-elbow | 1 |
107 | thickening/plaque | 1 |
108 | thickness-pressure | 1 |
109 | thickness/square | 1 |
110 | thickness/ösquare | 1 |
111 | tripidil | 1 |
112 | unrequited | 1 |
113 | vein-specific | 1 |
114 | wife-desired | 1 |
115 | zooanthellae | 1 |
1 | 16,689 | 1 |
2 | 19.1-26.2°c | 1 |
3 | 2.7l | 2 |
4 | 2/nl | 1 |
5 | 3-hydroxy-3-phenylpropanoate | 1 |
6 | 300-900°c | 1 |
7 | 57.2/year | 1 |
8 | 5750 | 2 |
9 | a-l. | 1 |
10 | a-peak | 1 |
11 | addo | 1 |
12 | ades-over-time | 1 |
13 | af.kidney | 1 |
14 | aminopeptidases | 4 |
15 | amiodarone-treatment | 1 |
16 | antimotion | 1 |
17 | area/total | 1 |
18 | bloom/wax | 2 |
19 | cac≥22 | 2 |
20 | chemoradiosensitivity | 4 |
21 | chromium/animal/day | 1 |
22 | clostridiumthermocellum | 1 |
23 | condoms/protection | 1 |
24 | cordgrass | 3 |
25 | crp/crp | 1 |
26 | d'hebron | 2 |
27 | date.an | 1 |
28 | defect/pulmonary | 1 |
29 | deficient/defective | 1 |
30 | dephenylation | 1 |
31 | dermatovenerology | 2 |
32 | dilitation | 2 |
33 | dose-timing | 3 |
34 | electroencephalogam | 1 |
35 | enzyme/hemodynamics | 1 |
36 | fontanel | 8 |
37 | fontanelle | 17 |
38 | frontal-temporal-limbic | 1 |
39 | gamma-frequency | 1 |
40 | gaze-following | 1 |
41 | head-imaging | 1 |
42 | hunger/satiety | 5 |
43 | hyper-crosslinked | 2 |
44 | hypertension/the | 1 |
45 | independent-components | 1 |
46 | invasion-like | 1 |
47 | iptsp | 1 |
48 | iqol | 2 |
49 | laminectomy/discectomy | 1 |
50 | ld50/bee/day | 1 |
51 | letters/digits | 1 |
52 | life-100bref | 2 |
53 | mahé | 1 |
54 | mass/end | 1 |
55 | maxilla-mandibular | 1 |
56 | micro-embolisation | 1 |
57 | microscotomas | 3 |
58 | mitral-peak | 1 |
59 | motion | 6,103 |
60 | movement×mirror | 1 |
61 | myofibres | 8 |
62 | near-falls | 1 |
63 | neseritide | 1 |
64 | npsuns | 2 |
65 | nrs≥5 | 1 |
66 | orizaba | 1 |
67 | oscata | 1 |
68 | palf-702 | 1 |
69 | paresthaesia | 1 |
70 | passivator | 1 |
71 | patient-actors | 1 |
72 | pb1-egfp | 1 |
73 | pdcai | 1 |
74 | pellitory | 4 |
75 | perimitral | 2 |
76 | periventricularis-nucleus | 2 |
77 | pneumococcusuria | 1 |
78 | polypharmacy-related | 1 |
79 | ponv/motion | 1 |
80 | porthole | 1 |
81 | pre-rrnp | 3 |
82 | prefrontals | 1 |
83 | pronation/supination | 8 |
84 | pulses/heifer | 1 |
85 | putamenat | 1 |
86 | rhophylac | 1 |
87 | running.future | 1 |
88 | score/standard | 1 |
89 | segment-lengthening | 1 |
90 | self-motion | 24 |
91 | semifundoplication | 5 |
92 | skull-induced | 1 |
93 | spondyloarthritis | 117 |
94 | stress-endocardial | 1 |
95 | stress-length | 4 |
96 | stress-lvef | 2 |
97 | stress-rate-corrected | 2 |
98 | stress-velocity | 10 |
99 | stress/fractional | 3 |
100 | stress/rate-corrected | 2 |
101 | striation | 3 |
102 | supermicropores | 1 |
103 | surgeons-elbow | 1 |
104 | synechiae | 75 |
105 | thickening/plaque | 1 |
106 | thickness-pressure | 1 |
107 | thickness/square | 1 |
108 | thickness/ösquare | 1 |
109 | tripidil | 1 |
110 | unrequited | 1 |
111 | vein-specific | 1 |
112 | wall-motion | 55 |
113 | wife-desired | 1 |
114 | zooanthellae | 1 |
115 | β1,6-glucans | 2 |
1 | a-l. | 1 |
2 | 5750 | 2 |
3 | palf-702 | 1 |
4 | cac≥22 | 2 |
5 | nrs≥5 | 1 |
6 | 16,689 | 1 |
7 | orizaba | 1 |
8 | pneumococcusuria | 1 |
9 | paresthaesia | 1 |
10 | oscata | 1 |
11 | rhophylac | 1 |
12 | frontal-temporal-limbic | 1 |
13 | vein-specific | 1 |
14 | 300-900°c | 1 |
15 | 19.1-26.2°c | 1 |
16 | skull-induced | 1 |
17 | hyper-crosslinked | 2 |
18 | wife-desired | 1 |
19 | polypharmacy-related | 1 |
20 | stress-rate-corrected | 2 |
21 | stress/rate-corrected | 2 |
22 | unrequited | 1 |
23 | mass/end | 1 |
24 | score/standard | 1 |
25 | synechiae | 75 |
26 | zooanthellae | 1 |
27 | neseritide | 1 |
28 | hypertension/the | 1 |
29 | invasion-like | 1 |
30 | fontanelle | 17 |
31 | porthole | 1 |
32 | ades-over-time | 1 |
33 | thickness/square | 1 |
34 | thickness/ösquare | 1 |
35 | thickness-pressure | 1 |
36 | running.future | 1 |
37 | 3-hydroxy-3-phenylpropanoate | 1 |
38 | thickening/plaque | 1 |
39 | deficient/defective | 1 |
40 | life-100bref | 2 |
41 | stress-lvef | 2 |
42 | head-imaging | 1 |
43 | dose-timing | 3 |
44 | segment-lengthening | 1 |
45 | gaze-following | 1 |
46 | stress-length | 4 |
47 | pdcai | 1 |
48 | a-peak | 1 |
49 | mitral-peak | 1 |
50 | 2.7l | 2 |
51 | stress-endocardial | 1 |
52 | stress/fractional | 3 |
53 | perimitral | 2 |
54 | area/total | 1 |
55 | fontanel | 8 |
56 | tripidil | 1 |
57 | 2/nl | 1 |
58 | iqol | 2 |
59 | electroencephalogam | 1 |
60 | clostridiumthermocellum | 1 |
61 | date.an | 1 |
62 | semifundoplication | 5 |
63 | striation | 3 |
64 | dephenylation | 1 |
65 | pronation/supination | 8 |
66 | micro-embolisation | 1 |
67 | dilitation | 2 |
68 | condoms/protection | 1 |
69 | motion | 6,103 |
70 | self-motion | 24 |
71 | wall-motion | 55 |
72 | ponv/motion | 1 |
73 | antimotion | 1 |
74 | d'hebron | 2 |
75 | addo | 1 |
76 | pb1-egfp | 1 |
77 | pre-rrnp | 3 |
78 | crp/crp | 1 |
79 | iptsp | 1 |
80 | 57.2/year | 1 |
81 | maxilla-mandibular | 1 |
82 | pulses/heifer | 1 |
83 | movement×mirror | 1 |
84 | passivator | 1 |
85 | microscotomas | 3 |
86 | enzyme/hemodynamics | 1 |
87 | myofibres | 8 |
88 | supermicropores | 1 |
89 | aminopeptidases | 4 |
90 | spondyloarthritis | 117 |
91 | prefrontals | 1 |
92 | near-falls | 1 |
93 | β1,6-glucans | 2 |
94 | npsuns | 2 |
95 | patient-actors | 1 |
96 | cordgrass | 3 |
97 | letters/digits | 1 |
98 | independent-components | 1 |
99 | periventricularis-nucleus | 2 |
100 | putamenat | 1 |
101 | amiodarone-treatment | 1 |
102 | surgeons-elbow | 1 |
103 | bloom/wax | 2 |
104 | ld50/bee/day | 1 |
105 | chromium/animal/day | 1 |
106 | gamma-frequency | 1 |
107 | af.kidney | 1 |
108 | dermatovenerology | 2 |
109 | laminectomy/discectomy | 1 |
110 | defect/pulmonary | 1 |
111 | pellitory | 4 |
112 | hunger/satiety | 5 |
113 | stress-velocity | 10 |
114 | chemoradiosensitivity | 4 |
115 | mahé | 1 |